阿司匹林-话题@MedSci

#阿司匹林#

178篇内容 | 7447人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2106310, encodeId=5dc7210631073, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=46, createdTime=2022-12-16, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2094005, encodeId=579e209400532, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>未病先防，已病防变。, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=55, createdTime=2022-10-16, rootId=0, userName=DIfh, userId=fa625399541, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1249464, encodeId=cb4f124946416, content=<a href='/topic/show?id=eb103e35fe' target=_blank style='color:#2F92EE;'>#Brilinta#</a>（即<a href='/topic/show?id=43666034930' target=_blank style='color:#2F92EE;'>#替格瑞洛#</a>）联合<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>用于<a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>，这些高风险人群，可能获益会更多一些, objectTitle=替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险, objectType=article, longId=178639, objectId=33d51e8639b9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201909/20190902161749110.jpeg, objectUrl=/article/show_article.do?id=33d51e8639b9, replyNumber=0, likeNumber=112, createdTime=2022-09-17, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d51e8639b9, moduleTitle=替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33d51e8639b9)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1249458, encodeId=c7021249458a0, content=<a href='/topic/show?id=eb103e35fe' target=_blank style='color:#2F92EE;'>#Brilinta#</a>（即<a href='/topic/show?id=43666034930' target=_blank style='color:#2F92EE;'>#替格瑞洛#</a>）联合<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>：III期研究证实继发性<a href='/topic/show?id=fa10e93597f' target=_blank style='color:#2F92EE;'>#缺血性卒中#</a><a href='/topic/show?id=ec01226163e' target=_blank style='color:#2F92EE;'>#中风#</a>死亡率降低17%, objectTitle=Brilinta联合阿司匹林：III期研究证实继发性中风死亡率降低17%, objectType=article, longId=197637, objectId=bcef19e637ac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020716/1594895387673_5085975.jpg, objectUrl=/article/show_article.do?id=bcef19e637ac, replyNumber=0, likeNumber=110, createdTime=2022-09-17, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcef19e637ac, moduleTitle=Brilinta联合阿司匹林：III期研究证实继发性中风死亡率降低17%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcef19e637ac)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1221008, encodeId=ba99122100871, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习新知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=73, createdTime=2022-05-19, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220455, encodeId=99541220455c6, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>、氯吡格雷、<a href='/topic/show?id=43666034930' target=_blank style='color:#2F92EE;'>#替格瑞洛#</a>, objectTitle=阿司匹林、氯吡格雷、替格瑞洛…..抗血小板药物全面总结！, objectType=article, longId=292052, objectId=e05b29205282, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211216/1639644756377_92910.png, objectUrl=/article/show_article.do?id=e05b29205282, replyNumber=0, likeNumber=105, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e05b29205282, moduleTitle=阿司匹林、氯吡格雷、替格瑞洛…..抗血小板药物全面总结！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e05b29205282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220297, encodeId=fe96122029e7a, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=74, createdTime=2022-05-17, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1219368, encodeId=70e81219368a8, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习新知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=67, createdTime=2022-05-13, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218825, encodeId=1d70121882547, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习新知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=64, createdTime=2022-05-11, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218541, encodeId=e8b51218541c1, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习新知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=61, createdTime=2022-05-10, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218182, encodeId=65561218182e7, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习学习新知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=58, createdTime=2022-05-09, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1217903, encodeId=98cc121e903ca, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=71, createdTime=2022-05-08, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1217637, encodeId=0c61121e6372b, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=63, createdTime=2022-05-07, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1216802, encodeId=54d0121680210, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=54, createdTime=2022-05-04, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1215793, encodeId=6a2c1215e936a, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习学习, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=50, createdTime=2022-04-30, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214242, encodeId=ecd5121424270, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>与<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a>, objectTitle=Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率, objectType=article, longId=300192, objectId=89be30019253, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202237/1646621686973_92910.png, objectUrl=/article/show_article.do?id=89be30019253, replyNumber=0, likeNumber=107, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89be30019253, moduleTitle=Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89be30019253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214241, encodeId=2f4112142414e, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>与<a href='/topic/show?id=e37c83513be' target=_blank style='color:#2F92EE;'>#胆管癌#</a>, objectTitle=“神药”阿司匹林又添新功效，或将治疗胆道癌！, objectType=article, longId=725433, objectId=6c9fe254337c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220424/60a6cfabcf6d4883985965a1e1e7e7f4.jpg, objectUrl=/article/show_article.do?id=6c9fe254337c, replyNumber=0, likeNumber=87, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c9fe254337c, moduleTitle=“神药”阿司匹林又添新功效，或将治疗胆道癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c9fe254337c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1212955, encodeId=0ab6121295550, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习知识, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=45, createdTime=2022-04-20, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1212256, encodeId=12b21212256b5, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习充电, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=48, createdTime=2022-04-18, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1211813, encodeId=4a3b121181366, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>学习学习, objectTitle=阿司匹林, objectType=topic, longId=97734, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605777398754_4754896.png, objectUrl=null, replyNumber=0, likeNumber=55, createdTime=2022-04-17, rootId=0, userName=ms3000000877658330, userId=364b6401448, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

人类三大神药之一！

2020-05-29

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习知识

2022-12-16

DIfh (审核中...)

前往app查看评论内容

#阿司匹林#未病先防，已病防变。

2022-10-16

(审核中...)

前往app查看评论内容

#Brilinta#（即#替格瑞洛#）联合#阿司匹林#用于#冠心病##糖尿病#，这些高风险人群，可能获益会更多一些

替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险

2022-09-17

(审核中...)

前往app查看评论内容

#Brilinta#（即#替格瑞洛#）联合#阿司匹林#：III期研究证实继发性#缺血性卒中##中风#死亡率降低17%

Brilinta联合阿司匹林：III期研究证实继发性中风死亡率降低17%

2022-09-17

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习新知识

2022-05-19

赛华佗 (审核中...)

前往app查看评论内容

#阿司匹林#、氯吡格雷、#替格瑞洛#

阿司匹林、氯吡格雷、替格瑞洛…..抗血小板药物全面总结！

2022-05-17

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习知识

2022-05-17

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习新知识

2022-05-13

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习新知识

2022-05-11

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习新知识

2022-05-10

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习学习新知识

2022-05-09

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习

2022-05-08

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习

2022-05-07

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习知识

2022-05-04

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习学习

2022-04-30

病毒猎手 (审核中...)

前往app查看评论内容

#阿司匹林#与#胃癌#

Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率

2022-04-25

病毒猎手 (审核中...)

前往app查看评论内容

#阿司匹林#与#胆管癌#

“神药”阿司匹林又添新功效，或将治疗胆道癌！

2022-04-25

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习知识

2022-04-20

ms300 (审核中...)

前往app查看评论内容

#阿司匹林#学习充电

2022-04-18

ms3000000877658330 (审核中...)

前往app查看评论内容

#阿司匹林#学习学习

2022-04-17

科室
- - 订阅+
  - 更多科室
工具
服务